Skip to search formSkip to main contentSkip to account menu

Dose Modification

Change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Therapeutic effects of ruxolitinib in patients with myelofibrosis without clinically significant splenomegaly.
To the editor: Ruxolitinib is the first JAK inhibitor approved as therapy for high- and intermediate-risk myelofibrosis (MF… 
2012
2012
Practical Approaches to the Use of Lenalidomide in Multiple Myeloma: A Canadian Consensus
In Canada, lenalidomide combined with dexamethasone (Len/Dex) is approved for use in relapsed or refractory multiple myeloma… 
2010
2010
Dose intensity analysis of high‐dose carboplatin in refractory ovarian carcinoma relative to age
Background. Cisplatin and carboplatin are essential to management of advanced‐stage epithelial ovarian carcinoma. No published… 
Highly Cited
2006
Highly Cited
2006
Correlation between image noise and body weight in coronary CTA with 16-row MDCT.
2006
2006
Dose modification factors for 192Ir high‐dose‐rate irradiation using Monte Carlo simulations
A recently introduced brachytherapy system for partial breast irradiation, MammoSite, consists of a balloon applicator filled… 
2000
2000
Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis.
Highly Cited
1995
Highly Cited
1995
Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
Review
1993
Review
1993
Combined carboplatin and cisplatin. Limited Prospects for Dose Intensification
Background. The relative lack of overlapping toxic‐ities and less‐than‐complete cross‐resistance of tumors treated with both… 
1988
1988
Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
1986
1986
The combined effect of bleomycin and irradiation on mouse lip mucosa. 2. Influence on the accumulation and repair of sublethal damage during fractionated irradiation.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)